Galaxy Surfactants Limited announced its unaudited financial results for Q2FY27 and H1FY27 ended September 30, 2026, in compliance with Regulation 30(2) of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
The disclosure was signed by Niranjan Arun Ketkar, Company Secretary, and filed with both National Stock Exchange of India Limited and BSE Limited.
Key Financial Performance
Quarterly Performance (Q2FY27 vs Q2FY26):
- Total Revenue: ₹1,816.8 crore, up 36.4% from ₹1,332.0 crore
- EBITDA: ₹195.9 crore, up 68.4% from ₹116.3 crore
- EBITDA Margin: 10.8% compared to 8.7%
- PAT: ₹119.8 crore, up 80.1% from ₹66.5 crore
- PAT Margin: 6.6% compared to 5.0%
Half-Yearly Performance (H1FY27 vs H1FY26):
- Total Revenue: ₹3,602.0 crore, up 37.4% from ₹2,621.1 crore
- EBITDA: ₹448.4 crore, up 78.4% from ₹251.4 crore
- EBITDA Margin: 12.4% compared to 9.6%
- PAT: ₹285.7 crore, up 95.7% from ₹146.0 crore
- PAT Margin: 7.9% compared to 1.2%
Full Year FY26 Reference:
- Total Revenue: ₹5,270.4 crore
- EBITDA: ₹497.4 crore
- PAT: ₹267.4 crore
Operational Highlights
Volume Performance:
- Consolidated volumes registered high-single-digit growth year-on-year
- India region: Mid-teens growth
- AMET region: Mid-teens growth in Q2, mid-single digit growth in H1
- Rest of World: High single-digit decline due to logistics disruptions and elevated freight costs
Product Category Performance:
- Performance Surfactant: Mid-teens growth in Q2, high single-digit growth in H1
- Specialty Care: Flat to low single-digit growth
Category-wise Revenue Breakdown:
- Q2FY27: Performance Surfactant ₹1,175 crore, Specialty Care ₹635 crore (Total ₹1,810 crore)
- H1FY27: Performance Surfactant ₹2,304 crore, Specialty Care ₹1,288 crore (Total ₹3,592 crore)
Management Commentary
Managing Director K. Natarajan commented on the strong performance, highlighting:
- Broad-based growth in India and continued recovery in AMET regions
- Sustained momentum in Specialty Care products
- Disciplined commercial decisions and diversified portfolio driving performance
- PAT for first six months of FY27 (₹285.7 crore) has already surpassed full FY26 PAT (₹267.4 crore)
- Demand indicators remain encouraging across key markets
- Company remains vigilant regarding developments in West Asia and potential implications for global logistics, freight rates, and feedstock availability
Company Background
Galaxy Surfactants Limited is a leading manufacturer of performance surfactants and specialty care products with over 215 product grades used in Home and Personal Care industry. The company supplies to leading MNCs, regional and local FMCG brands including Unilever, Reckitt Benckiser, P&G, L'OREAL, Himalaya, Colgate Palmolive, and CavinKare. Manufacturing facilities are located in India (5), Egypt (1), and USA (1).
Additional Information
The results announcement includes standard safe harbor statement regarding forward-looking statements. Investor contact information is provided: Mr. Ruchir Soni for the company and Strategic Growth Advisors Pvt. Ltd. for investor relations.